Condition

Tuberous Sclerosis

ClinicalTrials.gov condition label

Clinical trials42

Recruiting10

Common interventions25

Lead sponsors shown15

Clinical trials

42 shown

Sertraline vs. Placebo in the Treatment of Anxiety in Children and AdoLescents With NeurodevelopMental DisordersNCT06081348 · 2024-09-16

Qualitative Study in Patients With Genodermatoses and Healthcare Professionals on Reproductive CounsellingNCT06330350 · 2024-01-01

Genetic Bases of Neuroendocrine Neoplasms in Mexican PatientsNCT06523582 · 2022-08-03

GROWing Up With Rare GENEtic SyndromesNCT04463316 · 2018-10-01

Familial Investigations of Childhood Cancer PredispositionNCT03050268 · 2017-04-06

TSC Biosample Repository and Natural History DatabaseNCT05676099 · 2016-01-01

National Registry of Rare Kidney DiseasesNCT06065852 · 2009-11-06

Study of Skin Tumors in Tuberous SclerosisNCT00001975 · 2000-01-26

Role of Genetic Factors in the Development of Lung DiseaseNCT00001532 · 1996-09-13

Study of the Disease Process of LymphangioleiomyomatosisNCT00001465 · 1995-12-18

Neurocutaneous Syndromes in Children: Prevalence and Clinical CharacteristicsNCT07843823 · 2026-09-20

NOT_YET_RECRUITING

Reproductive Options in Inherited Skin DiseasesNCT06330324 · 2024-01-01

ENROLLING_BY_INVITATION

Web Intervention for Parents of Youth With Genetic Syndromes (WINGS)NCT06139172 · 2023-09-15

ACTIVE_NOT_RECRUITING

Remote Assessment and Intervention for Behavior Problems in Kids With TSCNCT06311474 · 2022-08-01

KidneYou - Innovative Digital TherapyNCT05286632 · 2022-07-18

Gait in Rare DiseasesNCT05161494 · 2022-01-25

Clinical Trial Data Set Re-use With Statistical Methodologies Tailored for Clinical Trials in Rare DiseasesNCT05199402 · 2021-07-01

Adjunctive Ganaxolone Treatment (Part A) in TSC Followed by Long-term Treatment (Part B)NCT04285346 · 2020-04-08

Dose-Ranging Efficacy and Safety Study of Topical Rapamycin Cream for Facial Angiofibroma Associated With Tuberous Sclerosis ComplexNCT03826628 · 2019-07-28

Parent and Infant Inter(X)Action Intervention (PIXI)NCT03836300 · 2018-11-30

ENROLLING_BY_INVITATION

Use of a Tonometer to Identify Epileptogenic Lesions During Pediatric Epilepsy SurgeryNCT04344626 · 2018-07-16

Turmeric as Treatment in EpilepsyNCT03254680 · 2018-03-01

JASPER Early Intervention for Tuberous SclerosisNCT03422367 · 2017-10-24

Topical Sirolimus Ointment for Cutaneous Angiofibromas in Subjects With Tuberous Sclerosis ComplexNCT03363763 · 2017-04-12

Characterization of Patients With Tuberous Sclerosis Complex, Lymphangioleiomyomatosis and AngiomyolipomaNCT02325505 · 2016-04-01

Phase III Trial of Topical Formulation of Sirolimus to Skin Lesions in Patients With Tuberous Sclerosis Complex (TSC)NCT02635789 · 2015-12-01

Long-term Trial of Topical Sirolimus to Angiofibroma in Patient With Tuberous Sclerosis ComplexNCT02634931 · 2015-12-01

Treatment of Renal Angiomyolipomas in Tuberous Sclerosis by Beta-blockersNCT02104011 · 2015-05-22

Autism Spectrum Disorder (ASD) and Intellectual Disability (ID) Determinants in Tuberous Sclerosis Complex (TSC)NCT02461459 · 2015-05-01

ACTIVE_NOT_RECRUITING

A Study of Everolimus in the Treatment of Neurocognitive Problems in Tuberous SclerosisNCT01954693 · 2012-06-01

Topical Rapamycin to Erase Angiofibromas in TSCNCT01526356 · 2012-05-01

Studies of Autistic Patients: Gene Networks and Clinical SubtypesNCT01092208 · 2010-03-17

Topical Rapamycin Therapy to Alleviate Cutaneous Manifestations of Tuberous Sclerosis Complex (TSC) and Neurofibromatosis I (NF1)NCT01031901 · 2009-12-01

Efficacy and Safety of Everolimus (RAD001) in Patients of All Ages With Subependymal Giant Cell Astrocytoma Associated With Tuberous Sclerosis Complex (TSC)(EXIST-1)NCT00789828 · 2009-08-01

Doxycycline In Lymphangioleiomyomatosis (LAM)NCT00989742 · 2009-07-01

Long Term Follow Up for RAD001 Therapy of Angiomyolipomata in Patients With Tuberous Sclerosis (TSC) and Sporadic Lymphangioleiomyomatosis (LAM)NCT00792766 · 2008-12-01

Effect of Fasting on the Size of Abdominal Lymphatic Tumors in WomenNCT00552955 · 2007-10-26

Everolimus (RAD001) Therapy of Giant Cell Astrocytoma in Patients With Tuberous Sclerosis ComplexNCT00411619 · 2007-01-01

RAPAMYCIN FOR KIDNEY ANGIOMYOLIPOMASNCT00126672 · 2005-12-20

Trial of Efficacy and Safety of Sirolimus in Tuberous Sclerosis and LAMNCT00490789 · 2005-10-01

RAD001 Therapy of Angiomyolipomata in Patients With TS Complex and Sporadic LAMNCT00457964 · 2005-08-01

Rapamycin Therapy for Patients With Tuberous Sclerosis Complex and Sporadic LAMNCT00457808 · 2002-12-01

Common interventions

Leading sponsors

Children's Hospital Medical Center, Cincinnati4 National Heart, Lung, and Blood Institute (NHLBI)4 University of California, Los Angeles3 Cardiff University2 Maastricht University Medical Center2 Nobelpharma2 The University of Texas Health Science Center, Houston2 Advice Pharma Group srl1 Assiut University1 Aucta Pharmaceuticals, Inc1 Boston Children's Hospital1 Dana-Farber Cancer Institute1 Dermatology Specialties Limited Partnership1 dr. Laura C. G. de Graaff-Herder1 Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)1

Trial status mix

COMPLETED19

RECRUITING10

TERMINATED3

UNKNOWN3

ACTIVE_NOT_RECRUITING2

ENROLLING_BY_INVITATION2

WITHDRAWN2

NOT_YET_RECRUITING1

Phase mix

PHASE213

NA7

PHASE14

PHASE34

PHASE41

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.